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Up-regulation of acyl-coenzyme A:cholesterol acyltransferase cells [1]. Esterification of cholesterol by ACAT limits
(ACAT) in nephrotic syndrome. its solubility in the cell membrane lipids and promotes
Background. We have previously demonstrated that hyper- accumulation of cholesterol ester in the fat dropletscholesterolemia in rats with puromycin-induced nephrotic
within cytoplasm. Thus, normal ACAT activity preventssyndrome (NS) is associated with up-regulation of hepatic
potentially toxic accumulation of free cholesterol in vari-3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reduc-
tase and relative down-regulation of cholesterol 7-hydroxy- ous cell membranes. In addition, by modulating intracel-
lase (Ch-7), which represent the rate-limiting steps in choles- lular free cholesterol concentration, ACAT plays an im-
terol biosynthesis and catabolism. Expression of HMG-CoA portant role in regulation of the cellular cholesterolreductase is inhibited and Ch-7 is augmented by intracellular
signaling pathways [2, 3]. ACAT also plays a major rolefree cholesterol, which is avidly esterified by acyl-CoA:cholest-
in regulation of intestinal transport of cholesterol thaterol acyltransferase (ACAT). Therefore, we hypothesized that
NS may result in up-regulation of hepatic ACAT. is esterified by ACAT prior to incorporation in chylomi-
Methods. Hepatic tissue ACAT mRNA (Northern blot), crons and subsequent secretion into the lymphatic system
protein (Western blot) and enzymatic activity were determined [4, 5]. Moreover, ACAT-mediated esterification of cho-in rats with puromycin-induced NS, placebo-treated control
lesterol plays a part in production and release of veryrats and Nagase hypoalbuminemic (NAG) rats.
low-density lipoprotein (VLDL) by the liver [6–8]. Simi-Results. The NS group exhibited heavy proteinuria, hypoal-
buminemia, normal creatinine clearance, severe hypercholester- larly, by lowering the free cholesterol that regulates
olemia and hypertriglyceridemia. Despite severe hypoalbumi- 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)
nemia, NAG rats with inherited hypoalbuminemia exhibited reductase and cholesterol 7-hydroxylase (rate control-only a mild elevation of plasma cholesterol and triglycerides.
ling enzyme in cholesterol conversion to bile acids), ACATSevere hypercholesterolemia in the NS group was coupled
modulate hepatic cholesterol biosynthesis and catabo-with depressed liver tissue free cholesterol concentration and
marked increases in hepatic ACAT mRNA, protein and enzy- lism [9, 10] and thus plasma cholesterol concentration.
matic activity. In contrast, ACAT mRNA and protein contents Finally, ACAT contributes to cholesterol ester accumu-
of the liver were normal and ACAT activity was mildly elevated lation in macrophages and vascular tissue, hence, foamin the NAG group.
cell formation and atherosclerosis [11].Conclusions. NS results in marked up-regulation of hepatic
ACAT is a membrane-associated enzyme that is pri-ACAT, which is primarily due to proteinuria and not hypoal-
buminemia, since the latter alone, as seen in NAG rats, does marily localized in the endoplasmic reticulum. Recently,
not significantly impact ACAT expression. Elevated ACAT in Anderson et al identified two distinct forms of ACAT
NS can contribute to dysregulation of cholesterol biosynthesis in the hepatocytes of the African green monkey [12].
and catabolism by limiting the normal cholesterol signaling
One of the isoforms was similar to that originally clonedinvolved in regulation of these processes.
from human genomic DNA, which they termed ACAT-1,
and was ubiquitously expressed in all tissues. The second
Acyl-coenzyme A:cholesterol acyltransferase (ACAT) isoform, termed ACAT-2, was primarily expressed in
catalyzes intracellular esterification of cholesterol and the liver and intestine [12].
formation of cholesterol ester in nearly all mammalian Heavy glomerular proteinuria, also known as ne-
phrotic syndrome, is a common feature of numerous
primary and secondary nephropathies [13]. Hyperlipid-Key words: proteinuria, hyperlipidemia, ACAT, atherosclerosis, kid-
ney disease, cardiovascular disease, cholesterol metabolism. emia is one of the cardinal manifestations of nephrotic
syndrome and is marked by elevations of plasma choles-Received for publication June 19, 2001
terol, triglycerides, low density lipoprotein (LDL), VLDL,and in revised form November 27, 2001
Accepted for publication December 17, 2001 lipoprotein(a) [LP(a)], and apolipoprotein-B and a de-
pressed ratio of cardioprotective cholesterol-rich high- 2002 by the International Society of Nephrology
1769
Vaziri and Liang: ACAT in nephrotic syndrome1770
density lipoprotein-2 (HDL-2) to cholesterol-poor HDL-3 Purina Mills Inc., Brentwood, MO, USA) and water.
Animals were randomized into the nephrotic (NS) andfraction [14–17]. In a series of earlier studies, we found
marked down-regulations of hepatic triglyceride lipase normal control groups. The rats assigned to the NS group
received sequential intraperitoneal injections of puromy-[18] as well as adipose tissue, skeletal and cardiac muscle
lipoprotein lipase [19] and VLDL receptor [20] in rats cin aminonucleoside on day 1 (130 mg/kg) and day 14 (60
mg/kg). The rats assigned to the control group receivedwith puromycin-induced nephrotic syndrome. These ab-
normalities can contribute to impaired clearance and placebo injections of 5% dextrose in water. In an attempt
to dissect the possible effect of proteinuria from that ofelevated plasma levels of triglyceride-rich lipoproteins
and their remnants in nephrotic syndrome. In addition, hypoalbuminemia, a group of male age-matched Nagase
hypoalbuminemic rats (Japan SLC Inc., Hamamatsu, Ja-recently we reported severe lecithin:cholesterol acyl-
transferase (LCAT) deficiency due to its massive urinary pan) was included as well. Thirty days after the initial
puromycin or placebo injections, animals (N  6 perlosses in nephrotic animals that accounts for impaired
HDL maturation in this condition [21]. We further found group) were placed in individual metabolic cages for a
24-hour urine collection. The next day, under generalthat induction and maintenance of severe hypercholes-
terolemia in rats with puromycin-induced nephrotic syn- anesthesia (Nembutal 50 mg/kg, IP), the animals were
sacrificed between the hours of 9 to 11 am, and the liverdrome is associated with increased hepatic HMG-CoA
reductase and inappropriately low hepatic cholesterol was immediately removed, frozen in liquid nitrogen and
stored at 70C for subsequent processing. In addition,7-hydroxylase expression [22, 23]. This was associated
with marked reduction of hepatic LDL receptor and blood was collected using cardiac puncture.
HDL receptor (SR B-I) proteins in this model [24, 25].
Western blot analysisAcquired LDL receptor deficiency can contribute to ele-
vated plasma concentration and depressed clearance of Frozen rat liver tissue was homogenized in 1 mL of
20 mmol/L Tris-HCl (pH 7.5) buffer containing 2 mmol/LLDL, while depressed hepatic HDL receptor can ac-
count for impaired HDL clearance in nephrotic syn- MgCl2, 0.2 mol/L sucrose, 5 mmol/L phenylmethylsulfo-
nyl fluoride (PMSF), 5 g/mL leupeptin, 10 g/mL apro-drome. Moreover, by limiting the hepatic uptake of cho-
lesterol-rich LDL and HDL particles, combined LDL tinin and 3 g/mL pepstatin A. The crude extract was
centrifuged at 12,000 g at 4C for 10 minutes to removereceptor and HDL receptor deficiencies can contribute
to the up-regulation of hepatic HMG-CoA reductase tissue debris. The supernatant was processed for deter-
mination of ACAT-2 abundance by Western blot and(the rate-determining step in cholesterol biosynthesis)
and relative reduction of cholesterol 7-hydroxylase (the protein concentration by a BCA protein assay kit (Pierce
Inc., Rockford, IL, USA). Aliquots containing 100 grate limiting enzyme in cholesterol catabolism) [22, 23].
This is because the local cholesterol pool plays a central proteins were fractionated on 4 to 20% Tris-glycine gel
(Novex Inc., San Diego, CA, USA) at 120 V for tworole in regulation of cholesterol-sensing enzymes and
proteins, such as the sterol regulatory element binding hours. After electrophoresis, proteins were transferred
to Hybond-ECL membrane (Amersham Life Scienceprotein, HMG-CoA reductase and cholesterol 7-hydrox-
ylase [2]. By catalyzing esterification of free cholesterol Inc., Arlington Heights, IL, USA). The membrane was
incubated for one hour in blocking buffer (1  TBS,within the endoplasmic reticulum and subsequent parti-
tioning of cholesterol ester in cytoplasmic storage drop- 0.1% Tween-20 and 7% nonfat milk) and then overnight
in the same buffer containing 1:5000 polyclonal ACAT-2lets, ACAT plays an important role in regulation of free
cholesterol pool and, hence, cholesterol-sensing enzymes antibody (generously provided by Professor Lawrence
L. Rudel, Department of Biochemistry and Comparativeand proteins. Based on these considerations, the present
study was designed to test the hypothesis that nephrotic Medicine, Wake Forest University, Winston-Salem, NC,
USA). Membrane was washed four times for 10 minutessyndrome may result in up-regulation of hepatic ACAT,
which in turn can contribute to the previously reported in 1  TBS, 0.1% Tween-20 prior to a two-hour incuba-
tion in blocking buffer plus diluted (1:6000) horseradishelevation of HMG-CoA reductase and relative reduction
of cholesterol 7-hydroxylase [22, 23] by lowering the peroxidase-linked anti-rabbit IgG (Amersham Life Sci-
ence Inc.). The washing procedure was repeated beforepool of free cholesterol in the endoplasmic reticulum.
the membranes were developed with chemiluminescent
agents (ECL; Amersham Life Science Inc.) and sub-
METHODS
jected to autoluminography for one minute.
Study groups
Northern blot analysisMale Sprague-Dawley rats weighing 180 to 200 g were
housed in a temperature- and light-controlled space with Total RNA was prepared from 0.2 g of frozen liver
tissue with RNAzol using the manufacturer’s recom-12-hour light (500 lux) and dark (5 lux) cycles. The
rats were allowed free access to food (Purina Rat Chow; mended procedure (Tel-Test Inc., Friendswood, TX,
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USA). RNA concentration was determined from the ration was determined by means of the BCA protein
assay kit (Pierce Inc.).absorbance at 260 nm using a spectrophotometer (Gene-
Two hundred microliters of the microsomal proteinQuat; Bio-Rad, Hercules, CA USA). Twenty microgram
were incubated with 20 L of the substrate mixture [0.25aliquots of total RNA were denatured in 2.2 mol/L form-
nmol fatty acid-free bovine serum albumin (BSA), 0.25aldehyde at 65C for 15 minutes and run on 1% agarose/
nmol [14C] oleyl-CoA in 104 mmol/L Tris, pH 7.8] in a2.2 mol/L formaldehyde gels at 40 V for five hours. The
total volume of 80 L at 37C for five minutes. At theseparated RNA was transferred to the nylon membrane
conclusion of the incubation period, the reaction was(Zeta probe; Bio-Rad) by capillary blotting in 6  so-
stopped by addition of 1.5 mL of 2:1 methanol:chloro-dium chloride, sodium citrate (SSC) buffer (0.9 mol/L
form mixture. Phase separation was accomplished byNaCl, 0.09 mol/L Na citrate, pH  7.0) overnight and
addition of 500L of water and 80 mg cholesterol oleate,immobilized by UV irradiation (Ultraviolet Crosslinker;
which served as internal standard for the thin layer chro-Fisher Scientific, Pittsburgh, PA, USA). The membrane
matography procedure. The chloroform layer containingwas incubated at 65C in a solution containing 5 SSPE
the lipid fraction was dried under nitrogen and resus-[0.75 mol/L NaCl, 0.05 mol/L NaH2PO4, 0.005 mol/L
pended in 60 L of ethyl acetate and separated on silicaethylenediaminetetraacetic acid (EDTA), pH 7.4], 5 
gel (Sigma Chemical Co., St. Louis, MO, USA) using aDenhard’s [Ficoll type 400), polyvinylpyrrolidone and
mixture of petroleum ether, anhydrous ether and aceticbovine serum albumin (BSA) 1 g/L each], 1% SDS (so-
acid (90:10:1) as the mobile phase. Thereafter, the choles-dium dodecyl sulfate) and 100 g/mL salmon sperm
terol ester bands were visualized by iodine vapor stain-DNA for 2 hours. The cDNA probe for monkey ACAT-
ing. The bands were then removed and transferred to2 (a 950 bp BamH I fragment) was generously supplied
scintillation vials prior to counting. The specific activityby Professor Lawrence L. Rudel and rat glyceraldehyde
of ACAT was expressed as picomoles of oleyl-CoA con-phosphate dehydrogenase (GAPDH; 1.3 Kb Pst I frag-
verted to steryl ester/min/1 mg protein.ment) was obtained from American Type Culture Collec-
tion (Rockville, MD, USA). Both probes were labeled Miscellaneous assays
with [32P] dCTP (3000 Ci/mmol; New England Nuclear
Urine protein concentration was determined by aInc., Boston, MA, USA) by the random primer method
quantitative colorimetric assay using a kit purchased(Promega Inc., Madison, WI, USA). Hybridization was
from Sigma Chemical Company. Serum albumin concen-carried out at 65C in a prehybridization solution with
tration was quantified by bromocresol green method em-32P labeled cDNA. The blots were washed twice in 2 
ploying a kit purchased from Wako Diagnostics andSSPE/0.5% SDS solution at room temperature, twice in
Chemicals USA, Inc. (Richmond, VA, USA). A colori-
1  SSPE/0.5% SDS solution at 37C and twice in 0.1 
metric assay was used to measure serum and urine creati-
SSPE/0.5% SDS solution at 65C, for 15 minutes each. nine concentrations using a kit obtained from Sigma
The washed blots were exposed to x-ray film (New En- Chemical Company. Plasma concentrations of total cho-
gland Nuclear Inc.) at80C for eight hours for GAPDH lesterol and hepatic tissue free cholesterol were mea-
and two days for ACAT-2. The autoradiographs were sured by enzymatic colorimetric assays using kits sup-
scanned with a laser densitometer (Molecular Dynamics, plied by Wako Diagnostics and Chemicals USA Inc.
Sunnyvale, CA, USA) to determine relative mRNA lev- Plasma HDL and LDL cholesterol concentrations and
els. The values obtained for GAPDH were used as the triglyceride level were determined by kits purchased from
internal control. Sigma Chemical Company.
Measurement of hepatic ACAT activity Data analysis
ACAT activity in the microsomal preparation was de- Analysis of variance (ANOVA), Duncan’s multiple
termined from the rate of [14C] oleyl-CoA incorporation range test and regression analysis were performed for
into steryl ester using a modification of the method de- statistical analysis of the data that are presented as
scribed by Chang et al [26]. Briefly, 200 mg of the frozen mean  SEM. P values less than 0.05 were considered
liver were homogenized in 3 mL of ice-cold buffer A statistically significant.
(50 mmol/L Tris, pH 7.8, 1 mmol/L EDTA and 1 mmol/L
PMSF) and the homogenate was centrifuged at 10,000 g
RESULTSfor 15 minutes at 4C. The microsome-enriched superna-
General findingstant was harvested and centrifuged at 100,000  g for
60 minutes. The pellet was resuspended in 2 mL of buffer Data are shown in Table 1. Compared with the control
A, then centrifuged at 100,000  g for 45 minutes at group, both nephrotic and Nagase rats exhibited marked
4C, and the final pellet was suspended in the same hypoalbuminemia. Hypoalbuminemia was associated with
severe proteinuria in the nephrotic group. However, uri-buffer. Protein concentration in this microsomal prepa-
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Table 1. Serum concentrations of total cholesterol, triglycerides, VLDL-cholesterol and albumin, serum HDL-chol/total chol ratio,
creatinine clearance (CCr), urinary protein excretion, body weight, systolic blood pressure and liver tissue free cholesterol
content in control (NL), nephritic (NS) and analbuminemic Nagase (NAG) rats
NL NS NAG P
Groups (N  6) (N  6) (N  6) (ANOVA)
Serum cholesterol mg/dL 67.43.9 293.326a 112.73.5 	0.001
Serum LDL mg/dL 36.94.0 193.518.4a 52.53.8 	0.001
Serum VLDL mg/dL 10.41.5 51.711.1a 23.62.7 	0.001
HDL/cholesterol ratio 0.30.05 0.20.04a 0.30.06 	0.003
Serum triglycerides mg/mL 50.86.5 229.928a 81.47.9 	0.001
Liver free cholesterol mg/g protein 16.10.6 12.71.1a 31.31.2 	0.001
Serum albumin g/dL 3.90.05 2.10.1a 0.130.02 	0.001
CCr mL/min 1.20.1 1.20.1 1.30.1 NS
Urine protein mg/24 h 7.71.0 26222a 8.21.0 0.001
Systolic pressure mm Hg 1204a 1455 1475 	0.01
Body weight g 27318 2226a 255 	0.05
Abbreviations are: VLDL, very low-density lipoprotein; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
aP 	 0.01, NS vs. other groups
nary protein excretion was normal in the Nagase rats.
No significant difference was found in serum creatinine
concentration or creatinine clearance among the study
groups. Compared to the control group, the NS group
showed a four-fold elevation of serum total cholesterol,
a nearly 4.5-fold increase in serum triglyceride concen-
tration and a significant reduction in serum HDL choles-
terol-to-total cholesterol concentration ratio. In contrast,
despite severe hypoalbuminemia, serum cholesterol and
triglyceride concentrations were only mildly elevated
and the HDL cholesterol-to-total cholesterol ratio was
normal in the Nagase rats. Hepatic tissue-free cholesterol
concentration was significantly reduced in the nephrotic
group when compared to the values observed in either
the normal control group or the Nagase animals.
ACAT mRNA, protein and activity
Data are depicted in Figures 1, 2 and 3. Liver-specific
ACAT-2 mRNA abundance in the nephrotic rats was
about threefold greater than that found in the normal
control group. In contrast, hepatic ACAT-2 mRNA
abundance was normal in the Nagase rats despite severe
hypoalbuminemia. Elevation of ACAT-2 mRNA abun-
dance in the nephrotic group was coupled with an even
Fig. 1. Representative Western blots (upper panel) and group datagreater increase in liver tissue ACAT-2 protein. Simi-
illustrating hepatic tissue acyl-CoA:cholesterol acyltransferase (ACAT)
larly, hepatic ACAT enzymatic activity was markedly protein abundance in the nephrotic (NS), Nagase hypoanalbuminemic
(NAG) and normal control (NL) groups. N  6 in each group. P 	elevated in the rats with nephrotic syndrome. However,
0.001.despite severe hypoalbuminemia, liver tissue ACAT-2
protein abundance was normal and hepatic ACAT activ-
ity was mildly elevated in the Nagase rats. These observa-
tions point to the role of proteinuria as the dominant observation points to the transcriptional regulation of
cause of the up-regulation of hepatic ACAT-2 expres- ACAT-2 in this setting. ACAT-2 protein abundance was
sion in the nephrotic animals. directly correlated with plasma total cholesterol (r 
0.95, P 	 0.01) suggesting causal association. A signifi-
Correlations cant positive correlation was found between urinary pro-
ACAT-2 protein abundance was directly related to tein excretion and hepatic tissue ACAT-2 protein abun-
dance (r  0.93, P 	 0.01). However, no correlation wasACAT-2 mRNA abundance (r  0.76, P 	 0.05). This
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Fig. 2. Representative Northern blots (upper panel) and group data
(lower panel) depicting hepatic tissue ACAT and GAPDH mRNA
abundance in the nephrotic (NS), Nagase hypoanalbuminemic (NAG)
and normal control (NL) groups. N  6 in each group. P 	 0.01.
Fig. 4. Correlations between hepatic tissue ACAT protein abundance
and serum cholesterol concentration (A), urinary protein excretion (B)
and plasma albumin (C) in the normal control (NL; ), nephrotic
syndrome (NS; ) and Nagase hypoalbuminemic (NG; ) groups. In
A, r  0.95, P 	 0.01; in B, r  0.93, P 	 0.01; in C, r  0.06, P  NS.
found between plasma albumin and ACAT-2 protein
level (r 0.06, PNS). The latter observation excludes
hypoalbuminemia as a possible cause of ACAT-2 over-
expression in the nephrotic animals (Fig. 4).
DISCUSSION
The nephrotic animals employed in the present study
exhibited a marked elevation of serum total cholesterol
concentration. Severe hypercholesterolemia in the ne-
phrotic animals was accompanied by parallel increasesFig. 3. Hepatic microsomal ACAT enzymatic activity in nephrotic
(NS), Nagase hypoanalbuminemic (NAG) and normal control (NL) in hepatic tissue ACAT-2 mRNA and protein abundance
groups. N  6 in each group. P 	 0.01. as well as enzymatic activity. Serum cholesterol concen-
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tration in the study animals was directly correlated with ated hypercholesterolemia and dysregulation of hepatic
cholesterol biosynthesis and catabolism in nephrotic syn-the liver tissue ACAT-2 abundance. These observations
suggest that overexpression of hepatic ACAT-2 may be drome. This phenomenon points to pharmacological in-
hibition of ACAT as a potential therapeutic approachinvolved in the pathogenesis of the nephrotic hypercho-
lesterolemia. Elevation of hepatic ACAT-2 abundance in the management of nephrotic hyperlipidemia and its
can potentially contribute to hypercholesterolemia by sev- long-term complications.
eral mechanisms. For instance, enhanced ACAT-media-
ted esterification of cholesterol in the endoplasmic retic- ACKNOWLEDGMENT
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